{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-032299","form_type":"8-K","ticker":"SMNR","cik":"0001913577","company_name":"Semnur Pharmaceuticals, Inc.","filed_at":"2025-04-16T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.457125+00:00","generated_at":"2026-05-23T13:56:40.371672+00:00","sec_items":["5.07","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"confidence":"high","headline":"Denali Capital shareholders approve extension to Dec 2025; ~708K shares redeemed for ~$8.6M","bullets":["Shareholders voted to extend business combination deadline to December 11, 2025, via up to 8 monthly extensions.","Holders of ~708,098 Class A shares redeemed for ~$8.6M (~$12.17/share); only 43,739 Class A shares remain outstanding.","Company deposited $874.78 into trust for first extension to May 11, 2025, funded by Scilex convertible note (up to $180K).","Scilex note bears no interest, convertible at $10/share; remaining $58,670.30 available for future extensions."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-032299","json":"https://secwatch.observer/filing/0001213900-25-032299.json","markdown":"https://secwatch.observer/filing/0001213900-25-032299.md","text":"https://secwatch.observer/filing/0001213900-25-032299.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1913577/000121390025032299/0001213900-25-032299-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1913577/000121390025032299/ea0238488-8k_denali.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T13:56:40.371672+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}